Cell cycle perturbations in acute myeloid leukemia samples following in vitro exposures to therapeutic agents (Q47994980)

7 February 2018

title

Cell cycle perturbations in acute myeloid leukemia samples following in vitro exposures to therapeutic agents (English)

1 reference

7 February 2018

1 reference

acute myeloid leukemia

1 reference

inferred from title

author

Frederick R. Appelbaum

5

object named as

F R Appelbaum

1 reference

7 February 2018

3

C L Willman

1 reference

7 February 2018

author name string

D E Banker

1

1 reference

7 February 2018

M Groudine

2

1 reference

7 February 2018

T Norwood

4

1 reference

7 February 2018

publication date

1 March 1998

1 reference

7 February 2018

published in

Leukemia Research

1 reference

7 February 2018

volume

22

1 reference

7 February 2018

issue

3

1 reference

7 February 2018

page(s)

221-239

1 reference

7 February 2018

UCN-01: a potent abrogator of G2 checkpoint function in cancer cells with disrupted p53.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2900174-4

7 January 2021

Apoptotic Cell Death During Treatment of Leukemias

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2900174-4

7 January 2021

Analysis of p53 gene mutations in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2900174-4

7 January 2021

Detection of p53 mutations using nonradioactive SSCP analysis: p53 is not frequently mutated in myelodysplastic syndromes (MDS)

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2900174-4

7 January 2021

Cell kinetics in leukaemia and solid tumours studied with in vivo bromodeoxyuridine and flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2900174-4

7 January 2021

Immunophenotyping of acute leukemia by flow cytometric analysis. Use of CD45 and right-angle light scatter to gate on leukemic blasts in three-color analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2900174-4

7 January 2021

Phase I clinical and laboratory evaluation of topotecan and cytarabine in patients with acute leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2900174-4

7 January 2021

Diminished cell proliferation associated with the death-protective activity of Bcl-2

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2900174-4

7 January 2021

Regulation of cell division cycle progression by bcl-2 expression: a potential mechanism for inhibition of programmed cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2900174-4

7 January 2021

The cell death inhibitor Bcl-2 and its homologues influence control of cell cycle entry

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2900174-4

7 January 2021

Modulation of cell kinetics and cell cycle status by treating CD34+ chronic myeloid leukaemia cells with p53 antisense phosphorothioate oligonucleotides.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2900174-4

7 January 2021

Selective induction of apoptosis in myeloid leukemic cell lines by monoacetone glucose-3 butyrate

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2900174-4

7 January 2021

Heterogeneous mechanisms of autocrine growth of AML blasts.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2900174-4

7 January 2021

10.1016/S0145-2126(97)00174-4

Identifiers

DOI

1 reference

7 February 2018

release_np44q5svnncopabtrm4xm2yk7m

Fatcat ID

0 references

1 reference

7 February 2018